Related Experiment Video
Updated: Aug 17, 2026
Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
Indirect immunoperoxidase test for the diagnosis of leptospirosis
Saichon Chimsumang1, Siriporn Chettanadee, Somchai Jitrathai
1Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Abstract:
Leptospirosis is a widespread zoonotic disease that affects all mammals, including humans, in different parts of the world. Clinical recognition of leptospirosis is challenging, and the definitive serologic diagnosis assay, the microscopic agglutination test (MAT), is time-consuming and difficult to conduct. In this study, an indirect immunoperoxidase (IIP) test to detect Leptospira-specific antibodies in human serum samples was developed. The efficacy of the IIP was compared with the indirect immunofluorescent assay (IFA) and MAT. A total of 368 human serum samples were analyzed by MAT, IFA, and IIP. Using a MAT titer of > or = 1:100 as the gold standard, the sensitivities for the detection of Leptospiral antibodies at a titer of 1:200 were 94.7% by IFA and 93.6% by IIP; specificities were 95.3% by IFA and 94.9% by IIP; and accuracies were 95.1% by IFA and 94.6% by IIP. With a titer of 1:400, the sensitivity, specificity, and accuracy were 86.2%, 98.9%, and 95.7% by IFA, respectively; whereas, for the IIP, the sensitivity was 85.1%, specificity 98.5%, and accuracy 95.1%. A further evaluation of this test with 80 unknown-febrile-disease sera was also included. We found that the sensitivity and specificity of this test were 100% and 76.8%, respectively. Therefore, the IIP test is a potentially valuable tool for the diagnosis of leptospirosis.
Insights
A new indirect immunoperoxidase (IIP) test offers a valuable tool for diagnosing leptospirosis, a widespread zoonotic disease. This assay demonstrates high sensitivity and specificity, providing a more accessible alternative to traditional diagnostic methods.
Area of Science:
- Medical Microbiology
- Immunology
- Infectious Diseases
Background:
- Leptospirosis is a global zoonotic disease affecting mammals, including humans.
- Clinical diagnosis is difficult, and the gold standard microscopic agglutination test (MAT) is labor-intensive.
- There is a need for efficient and reliable diagnostic tools for leptospirosis.
Purpose of the Study:
- To develop and evaluate an indirect immunoperoxidase (IIP) test for detecting Leptospira-specific antibodies in human serum.
- To compare the diagnostic performance of the IIP test against the indirect immunofluorescent assay (IFA) and the microscopic agglutination test (MAT).
Main Methods:
- An indirect immunoperoxidase (IIP) test was developed to detect antibodies against Leptospira.
- The IIP test was validated using 368 human serum samples and compared with IFA and MAT.
- Performance metrics including sensitivity, specificity, and accuracy were calculated at different antibody titers (1:200 and 1:400).
Main Results:
- At a titer of 1:200, IIP showed 93.6% sensitivity, 94.9% specificity, and 94.6% accuracy.
- At a titer of 1:400, IIP demonstrated 85.1% sensitivity, 98.5% specificity, and 95.1% accuracy.
- In an evaluation with unknown febrile disease sera, the IIP test achieved 100% sensitivity and 76.8% specificity.
Conclusions:
- The developed indirect immunoperoxidase (IIP) test is a promising diagnostic tool for leptospirosis.
- The IIP test offers comparable performance to IFA and is a potentially more practical alternative to MAT.
- This assay could improve the timely and accurate diagnosis of leptospirosis in clinical settings.
